Gennex Laboratories Limited (BOM:531739)
India · Delayed Price · Currency is INR 10.06
-0.25 (-2.42%)
At close: May 6, 2026
Gennex Laboratories Market Cap
Gennex Laboratories has a market cap or net worth of 2.44 billion as of May 6, 2026. Its market cap has decreased by -19.51% in one year.
Market Cap
2.44B
Enterprise Value
2.94B
Revenue
1.52B
Ranking
n/a
PE Ratio
13.47
Stock Price
10.06
Market Cap Chart
Since January 2, 2002, Gennex Laboratories's market cap has increased from 61.80M to 2.44B, an increase of 3,854.55%. That is a compound annual growth rate of 16.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 2.44B | -24.86% |
| Dec 31, 2025 | 3.25B | -12.43% |
| Dec 31, 2024 | 3.71B | 24.52% |
| Dec 29, 2023 | 2.98B | 160.77% |
| Dec 30, 2022 | 1.14B | -18.17% |
| Dec 31, 2021 | 1.40B | 135.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medicamen Biotech | 3.29B |
| Sat Kartar Life | 3.10B |
| Trident Lifeline | 3.00B |
| Speciality Medicines | 2.76B |
| Kerala Ayurveda | 2.70B |
| Everest Organics | 2.55B |
| Ambalal Sarabhai Enterprises | 2.48B |
| BDH Industries | 2.18B |